The global Transdermal Microarray Patches market was valued at US$ 405 million in 2025 and is anticipated to reach US$ 640 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Transdermal Microarray Patches Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transdermal Microarray Patches competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Transdermal Microarray Patches are skin-applied patches that carry a dense array of microscopic projections (microneedles) designed to painlessly breach the outer skin barrier and deposit a drug into the shallow skin layers for absorption. Depending on the design, the microprojections may be dissolving/biodegradable (releasing the dose as the tips dissolve), coated (drug layer transfers off the projections), solid (create microchannels for a separately applied formulation), or hollow (infuse a liquid). Because they can enable simple patch-like self-administration, avoid sharps waste, and potentially improve stability for certain formulations, microarray patches are being developed for vaccines, biologics, and small-molecule therapies where easier delivery and better adherence are valuable. Consumer/cosmetic microneedle patches typically cost between $0.75 and $1.60 per patch. Vaccine microarray patches (MAPs) cost between $0.85 and $5.00 per dose/patch.

Transdermal Microarray Patches sit at the intersection of pharma formulation and precision microfabrication. Upstream inputs include the active drug substance (small molecules, biologics, or vaccine antigens), stabilizing excipients (sugars, polymers, buffers, surfactants), and microneedle structural materials (dissolving polymers/sugars for soluble MAPs, or silicon/metal/ceramic/rigid polymers for insoluble designs), plus high-precision tooling and equipment (micro-molds, etching/laser machining, coating/casting and drying systems) and medical-grade converting materials (backing films, pressure-sensitive adhesives, liners, desiccants, foil pouches). Manufacturing then combines microneedle array formation, drug loading (tip-casting, matrix mixing, or surface coating), moisture-controlled drying/curing, lamination/assembly, and rigorous QC for dose uniformity, mechanical strength and insertion performance, extractables/leachables, and stability; depending on product, it may also include sterilization or aseptic controls and an applicator. Downstream, MAPs are supplied as combination products through clinical-trial and commercial channels, with packaging and logistics designed around humidity/temperature sensitivity and traceability; end users range from self-administration at home (chronic therapies) to clinics and mass-immunization programs, with training, labeling, and pharmacovigilance requirements that resemble both drug and device workflows.

The North American market for Transdermal Microarray Patches is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Transdermal Microarray Patches is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Transdermal Microarray Patches include Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Transdermal Microarray Patches market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Microarray Patches. The Transdermal Microarray Patches market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Transdermal Microarray Patches market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Transdermal Microarray Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Transdermal Microarray Patches Market Report

Report Metric	Details
Report Name	Transdermal Microarray Patches Market
Accounted market size in 2025	US$ 405 million
Forecasted market size in 2032	US$ 640 million
CAGR	6.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Dissolving Non-dissolving
Segment by Microneedle Material	Hyaluronic Acid Taurine Triple-helical Collagen PGA、PLA、PP
by Application	Medical Cosmetics
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Transdermal Microarray Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Transdermal Microarray Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Transdermal Microarray Patches Market growing?

Ans: The Transdermal Microarray Patches Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Transdermal Microarray Patches Market size in 2032?

Ans: The Transdermal Microarray Patches Market size in 2032 will be US$ 640 million.

Who are the main players in the Transdermal Microarray Patches Market report?

Ans: The main players in the Transdermal Microarray Patches Market are Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical

What are the Application segmentation covered in the Transdermal Microarray Patches Market report?

Ans: The Applications covered in the Transdermal Microarray Patches Market report are Medical, Cosmetics

What are the Type segmentation covered in the Transdermal Microarray Patches Market report?

Ans: The Types covered in the Transdermal Microarray Patches Market report are Dissolving, Non-dissolving

1 Transdermal Microarray Patches Market Overview

1.1 Product Definition

1.2 Transdermal Microarray Patches by Type

1.2.1 Global Transdermal Microarray Patches Market Value by Type: 2025 vs 2032

1.2.2 Dissolving

1.2.3 Non-dissolving

1.3 Transdermal Microarray Patches by Microneedle Material

1.3.1 Global Transdermal Microarray Patches Market Value by Microneedle Material: 2025 vs 2032

1.3.2 Hyaluronic Acid

1.3.3 Taurine

1.3.4 Triple-helical Collagen

1.3.5 PGA、PLA、PP

1.4 Transdermal Microarray Patches by Application

1.4.1 Global Transdermal Microarray Patches Market Value by Application: 2025 vs 2032

1.4.2 Medical

1.4.3 Cosmetics

1.5 Global Transdermal Microarray Patches Market Size Estimates and Forecasts

1.5.1 Global Transdermal Microarray Patches Revenue 2021–2032

1.5.2 Global Transdermal Microarray Patches Sales 2021–2032

1.5.3 Global Transdermal Microarray Patches Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2 Transdermal Microarray Patches Market Competition by Manufacturers

2.1 Global Transdermal Microarray Patches Sales Market Share by Manufacturers (2021–2026)

2.2 Global Transdermal Microarray Patches Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Transdermal Microarray Patches Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Transdermal Microarray Patches, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Transdermal Microarray Patches, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Transdermal Microarray Patches, Product Types and Applications

2.7 Global Key Manufacturers of Transdermal Microarray Patches, Date of Entry into the Industry

2.8 Global Transdermal Microarray Patches Market Competitive Situation and Trends

2.8.1 Global Transdermal Microarray Patches Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Transdermal Microarray Patches Players Market Share by Revenue

2.8.3 Global Transdermal Microarray Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Transdermal Microarray Patches Market Scenario by Region

3.1 Global Transdermal Microarray Patches Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Transdermal Microarray Patches Sales by Region: 2021–2032

3.2.1 Global Transdermal Microarray Patches Sales by Region: 2021–2026

3.2.2 Global Transdermal Microarray Patches Sales by Region: 2027–2032

3.3 Global Transdermal Microarray Patches Revenue by Region: 2021–2032

3.3.1 Global Transdermal Microarray Patches Revenue by Region: 2021–2026

3.3.2 Global Transdermal Microarray Patches Revenue by Region: 2027–2032

3.4 North America Transdermal Microarray Patches Market Facts & Figures by Country

3.4.1 North America Transdermal Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Transdermal Microarray Patches Sales by Country (2021–2032)

3.4.3 North America Transdermal Microarray Patches Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Transdermal Microarray Patches Market Facts & Figures by Country

3.5.1 Europe Transdermal Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Transdermal Microarray Patches Sales by Country (2021–2032)

3.5.3 Europe Transdermal Microarray Patches Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Transdermal Microarray Patches Market Facts & Figures by Region

3.6.1 Asia Pacific Transdermal Microarray Patches Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Transdermal Microarray Patches Sales by Region (2021–2032)

3.6.3 Asia Pacific Transdermal Microarray Patches Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Transdermal Microarray Patches Market Facts & Figures by Country

3.7.1 Latin America Transdermal Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Transdermal Microarray Patches Sales by Country (2021–2032)

3.7.3 Latin America Transdermal Microarray Patches Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Transdermal Microarray Patches Market Facts & Figures by Country

3.8.1 Middle East and Africa Transdermal Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Transdermal Microarray Patches Sales by Country (2021–2032)

3.8.3 Middle East and Africa Transdermal Microarray Patches Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Transdermal Microarray Patches Sales by Type (2021–2032)

4.1.1 Global Transdermal Microarray Patches Sales by Type (2021–2026)

4.1.2 Global Transdermal Microarray Patches Sales by Type (2027–2032)

4.1.3 Global Transdermal Microarray Patches Sales Market Share by Type (2021–2032)

4.2 Global Transdermal Microarray Patches Revenue by Type (2021–2032)

4.2.1 Global Transdermal Microarray Patches Revenue by Type (2021–2026)

4.2.2 Global Transdermal Microarray Patches Revenue by Type (2027–2032)

4.2.3 Global Transdermal Microarray Patches Revenue Market Share by Type (2021–2032)

4.3 Global Transdermal Microarray Patches Price by Type (2021–2032)

5 Segment by Application

5.1 Global Transdermal Microarray Patches Sales by Application (2021–2032)

5.1.1 Global Transdermal Microarray Patches Sales by Application (2021–2026)

5.1.2 Global Transdermal Microarray Patches Sales by Application (2027–2032)

5.1.3 Global Transdermal Microarray Patches Sales Market Share by Application (2021–2032)

5.2 Global Transdermal Microarray Patches Revenue by Application (2021–2032)

5.2.1 Global Transdermal Microarray Patches Revenue by Application (2021–2026)

5.2.2 Global Transdermal Microarray Patches Revenue by Application (2027–2032)

5.2.3 Global Transdermal Microarray Patches Revenue Market Share by Application (2021–2032)

5.3 Global Transdermal Microarray Patches Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Kindeva

6.1.1 Kindeva Company Information

6.1.2 Kindeva Description and Business Overview

6.1.3 Kindeva Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Kindeva Transdermal Microarray Patches Product Portfolio

6.1.5 Kindeva Recent Developments/Updates

6.2 Raphas

6.2.1 Raphas Company Information

6.2.2 Raphas Description and Business Overview

6.2.3 Raphas Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Raphas Transdermal Microarray Patches Product Portfolio

6.2.5 Raphas Recent Developments/Updates

6.3 CosMED Pharmaceutical

6.3.1 CosMED Pharmaceutical Company Information

6.3.2 CosMED Pharmaceutical Description and Business Overview

6.3.3 CosMED Pharmaceutical Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 CosMED Pharmaceutical Transdermal Microarray Patches Product Portfolio

6.3.5 CosMED Pharmaceutical Recent Developments/Updates

6.4 Vaxess Technologies

6.4.1 Vaxess Technologies Company Information

6.4.2 Vaxess Technologies Description and Business Overview

6.4.3 Vaxess Technologies Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Vaxess Technologies Transdermal Microarray Patches Product Portfolio

6.4.5 Vaxess Technologies Recent Developments/Updates

6.5 Micron Biomedical

6.5.1 Micron Biomedical Company Information

6.5.2 Micron Biomedical Description and Business Overview

6.5.3 Micron Biomedical Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Micron Biomedical Transdermal Microarray Patches Product Portfolio

6.5.5 Micron Biomedical Recent Developments/Updates

6.6 LTS Lohmann Therapie-Systeme

6.6.1 LTS Lohmann Therapie-Systeme Company Information

6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview

6.6.3 LTS Lohmann Therapie-Systeme Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 LTS Lohmann Therapie-Systeme Transdermal Microarray Patches Product Portfolio

6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates

6.7 ArrayPatch

6.7.1 ArrayPatch Company Information

6.7.2 ArrayPatch Description and Business Overview

6.7.3 ArrayPatch Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 ArrayPatch Transdermal Microarray Patches Product Portfolio

6.7.5 ArrayPatch Recent Developments/Updates

6.8 CeraVx

6.8.1 CeraVx Company Information

6.8.2 CeraVx Description and Business Overview

6.8.3 CeraVx Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 CeraVx Transdermal Microarray Patches Product Portfolio

6.8.5 CeraVx Recent Developments/Updates

6.9 Zhongke Microneedle (Beijing) Technology

6.9.1 Zhongke Microneedle (Beijing) Technology Company Information

6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview

6.9.3 Zhongke Microneedle (Beijing) Technology Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Zhongke Microneedle (Beijing) Technology Transdermal Microarray Patches Product Portfolio

6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

6.10 Zhuhai Youwe Biotechnology

6.10.1 Zhuhai Youwe Biotechnology Company Information

6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview

6.10.3 Zhuhai Youwe Biotechnology Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Zhuhai Youwe Biotechnology Transdermal Microarray Patches Product Portfolio

6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates

6.11 Youwei (Zhuhai) Biotechnology

6.11.1 Youwei (Zhuhai) Biotechnology Company Information

6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview

6.11.3 Youwei (Zhuhai) Biotechnology Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Youwei (Zhuhai) Biotechnology Transdermal Microarray Patches Product Portfolio

6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates

6.12 WCC Biomedical

6.12.1 WCC Biomedical Company Information

6.12.2 WCC Biomedical Description and Business Overview

6.12.3 WCC Biomedical Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 WCC Biomedical Transdermal Microarray Patches Product Portfolio

6.12.5 WCC Biomedical Recent Developments/Updates

6.13 Hisamitsu Pharmaceutical

6.13.1 Hisamitsu Pharmaceutical Company Information

6.13.2 Hisamitsu Pharmaceutical Description and Business Overview

6.13.3 Hisamitsu Pharmaceutical Transdermal Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Hisamitsu Pharmaceutical Transdermal Microarray Patches Product Portfolio

6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Transdermal Microarray Patches Industry Chain Analysis

7.2 Transdermal Microarray Patches Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Transdermal Microarray Patches Production Mode & Process Analysis

7.4 Transdermal Microarray Patches Sales and Marketing

7.4.1 Transdermal Microarray Patches Sales Channels

7.4.2 Transdermal Microarray Patches Distributors

7.5 Transdermal Microarray Patches Customer Analysis

8 Transdermal Microarray Patches Market Dynamics

8.1 Transdermal Microarray Patches Industry Trends

8.2 Transdermal Microarray Patches Market Drivers

8.3 Transdermal Microarray Patches Market Challenges

8.4 Transdermal Microarray Patches Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

KINDEVA

Raphas

Cosmed Pharmaceutical

Vaxess Technologies

Micron Biomedical

LTS Lohmann Therapie-Systeme

ArrayPatch

CeraVx

Zhongke Microneedle (Beijing) Technology

Zhuhai Youwe Biotechnology

Youwei (Zhuhai) Biotechnology

WCC Biomedical

Hisamitsu Pharmaceutical

List of Tables

Table 1. Global Transdermal Microarray Patches Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Transdermal Microarray Patches Market Value by Microneedle Material (US$ Million), 2025 vs 2032

Table 3. Global Transdermal Microarray Patches Market Value by Application (US$ Million), 2025 vs 2032

Table 4. Global Transdermal Microarray Patches Market Competitive Situation by Manufacturers in 2025

Table 5. Global Transdermal Microarray Patches Sales (K Pcs) of Key Manufacturers (2021–2026)

Table 6. Global Transdermal Microarray Patches Sales Market Share by Manufacturers (2021–2026)

Table 7. Global Transdermal Microarray Patches Revenue (US$ Million) by Manufacturers (2021–2026)

Table 8. Global Transdermal Microarray Patches Revenue Share by Manufacturers (2021–2026)

Table 9. Global Market Transdermal Microarray Patches Average Price (US$/Pc) of Key Manufacturers (2021–2026)

Table 10. Global Key Players of Transdermal Microarray Patches, Industry Ranking, 2023 vs 2024 vs 2025

Table 11. Global Key Manufacturers of Transdermal Microarray Patches, Manufacturing Sites and Headquarters

Table 12. Global Key Manufacturers of Transdermal Microarray Patches, Product Types and Applications

Table 13. Global Key Manufacturers of Transdermal Microarray Patches, Date of Entry into the Industry

Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Global Transdermal Microarray Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transdermal Microarray Patches Revenue, 2025

Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 17. Global Transdermal Microarray Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 18. Global Transdermal Microarray Patches Sales by Region (K Pcs), 2021–2026

Table 19. Global Transdermal Microarray Patches Sales Market Share by Region (2021–2026)

Table 20. Global Transdermal Microarray Patches Sales by Region (K Pcs), 2027–2032

Table 21. Global Transdermal Microarray Patches Sales Market Share by Region (2027–2032)

Table 22. Global Transdermal Microarray Patches Revenue by Region (US$ Million), 2021–2026

Table 23. Global Transdermal Microarray Patches Revenue Market Share by Region (2021–2026)

Table 24. Global Transdermal Microarray Patches Revenue by Region (US$ Million), 2027–2032

Table 25. Global Transdermal Microarray Patches Revenue Market Share by Region (2027–2032)

Table 26. North America Transdermal Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 27. North America Transdermal Microarray Patches Sales by Country (K Pcs), 2021–2026

Table 28. North America Transdermal Microarray Patches Sales by Country (K Pcs), 2027–2032

Table 29. North America Transdermal Microarray Patches Revenue by Country (US$ Million), 2021–2026

Table 30. North America Transdermal Microarray Patches Revenue by Country (US$ Million), 2027–2032

Table 31. Europe Transdermal Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 32. Europe Transdermal Microarray Patches Sales by Country (K Pcs), 2021–2026

Table 33. Europe Transdermal Microarray Patches Sales by Country (K Pcs), 2027–2032

Table 34. Europe Transdermal Microarray Patches Revenue by Country (US$ Million), 2021–2026

Table 35. Europe Transdermal Microarray Patches Revenue by Country (US$ Million), 2027–2032

Table 36. Asia Pacific Transdermal Microarray Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia Pacific Transdermal Microarray Patches Sales by Region (K Pcs), 2021–2026

Table 38. Asia Pacific Transdermal Microarray Patches Sales by Region (K Pcs), 2027–2032

Table 39. Asia Pacific Transdermal Microarray Patches Revenue by Region (US$ Million), 2021–2026

Table 40. Asia Pacific Transdermal Microarray Patches Revenue by Region (US$ Million), 2027–2032

Table 41. Latin America Transdermal Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 42. Latin America Transdermal Microarray Patches Sales by Country (K Pcs), 2021–2026

Table 43. Latin America Transdermal Microarray Patches Sales by Country (K Pcs), 2027–2032

Table 44. Latin America Transdermal Microarray Patches Revenue by Country (US$ Million), 2021–2026

Table 45. Latin America Transdermal Microarray Patches Revenue by Country (US$ Million), 2027–2032

Table 46. Middle East and Africa Transdermal Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 47. Middle East and Africa Transdermal Microarray Patches Sales by Country (K Pcs), 2021–2026

Table 48. Middle East and Africa Transdermal Microarray Patches Sales by Country (K Pcs), 2027–2032

Table 49. Middle East and Africa Transdermal Microarray Patches Revenue by Country (US$ Million), 2021–2026

Table 50. Middle East and Africa Transdermal Microarray Patches Revenue by Country (US$ Million), 2027–2032

Table 51. Global Transdermal Microarray Patches Sales (K Pcs) by Type (2021–2026)

Table 52. Global Transdermal Microarray Patches Sales (K Pcs) by Type (2027–2032)

Table 53. Global Transdermal Microarray Patches Sales Market Share by Type (2021–2026)

Table 54. Global Transdermal Microarray Patches Sales Market Share by Type (2027–2032)

Table 55. Global Transdermal Microarray Patches Revenue (US$ Million) by Type (2021–2026)

Table 56. Global Transdermal Microarray Patches Revenue (US$ Million) by Type (2027–2032)

Table 57. Global Transdermal Microarray Patches Revenue Market Share by Type (2021–2026)

Table 58. Global Transdermal Microarray Patches Revenue Market Share by Type (2027–2032)

Table 59. Global Transdermal Microarray Patches Price (US$/Pc) by Type (2021–2026)

Table 60. Global Transdermal Microarray Patches Price (US$/Pc) by Type (2027–2032)

Table 61. Global Transdermal Microarray Patches Sales (K Pcs) by Application (2021–2026)

Table 62. Global Transdermal Microarray Patches Sales (K Pcs) by Application (2027–2032)

Table 63. Global Transdermal Microarray Patches Sales Market Share by Application (2021–2026)

Table 64. Global Transdermal Microarray Patches Sales Market Share by Application (2027–2032)

Table 65. Global Transdermal Microarray Patches Revenue (US$ Million) by Application (2021–2026)

Table 66. Global Transdermal Microarray Patches Revenue (US$ Million) by Application (2027–2032)

Table 67. Global Transdermal Microarray Patches Revenue Market Share by Application (2021–2026)

Table 68. Global Transdermal Microarray Patches Revenue Market Share by Application (2027–2032)

Table 69. Global Transdermal Microarray Patches Price (US$/Pc) by Application (2021–2026)

Table 70. Global Transdermal Microarray Patches Price (US$/Pc) by Application (2027–2032)

Table 71. Kindeva Company Information

Table 72. Kindeva Description and Business Overview

Table 73. Kindeva Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 74. Kindeva Transdermal Microarray Patches Product

Table 75. Kindeva Recent Developments/Updates

Table 76. Raphas Company Information

Table 77. Raphas Description and Business Overview

Table 78. Raphas Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 79. Raphas Transdermal Microarray Patches Product

Table 80. Raphas Recent Developments/Updates

Table 81. CosMED Pharmaceutical Company Information

Table 82. CosMED Pharmaceutical Description and Business Overview

Table 83. CosMED Pharmaceutical Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 84. CosMED Pharmaceutical Transdermal Microarray Patches Product

Table 85. CosMED Pharmaceutical Recent Developments/Updates

Table 86. Vaxess Technologies Company Information

Table 87. Vaxess Technologies Description and Business Overview

Table 88. Vaxess Technologies Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 89. Vaxess Technologies Transdermal Microarray Patches Product

Table 90. Vaxess Technologies Recent Developments/Updates

Table 91. Micron Biomedical Company Information

Table 92. Micron Biomedical Description and Business Overview

Table 93. Micron Biomedical Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 94. Micron Biomedical Transdermal Microarray Patches Product

Table 95. Micron Biomedical Recent Developments/Updates

Table 96. LTS Lohmann Therapie-Systeme Company Information

Table 97. LTS Lohmann Therapie-Systeme Description and Business Overview

Table 98. LTS Lohmann Therapie-Systeme Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 99. LTS Lohmann Therapie-Systeme Transdermal Microarray Patches Product

Table 100. LTS Lohmann Therapie-Systeme Recent Developments/Updates

Table 101. ArrayPatch Company Information

Table 102. ArrayPatch Description and Business Overview

Table 103. ArrayPatch Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 104. ArrayPatch Transdermal Microarray Patches Product

Table 105. ArrayPatch Recent Developments/Updates

Table 106. CeraVx Company Information

Table 107. CeraVx Description and Business Overview

Table 108. CeraVx Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 109. CeraVx Transdermal Microarray Patches Product

Table 110. CeraVx Recent Developments/Updates

Table 111. Zhongke Microneedle (Beijing) Technology Company Information

Table 112. Zhongke Microneedle (Beijing) Technology Description and Business Overview

Table 113. Zhongke Microneedle (Beijing) Technology Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 114. Zhongke Microneedle (Beijing) Technology Transdermal Microarray Patches Product

Table 115. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates

Table 116. Zhuhai Youwe Biotechnology Company Information

Table 117. Zhuhai Youwe Biotechnology Description and Business Overview

Table 118. Zhuhai Youwe Biotechnology Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 119. Zhuhai Youwe Biotechnology Transdermal Microarray Patches Product

Table 120. Zhuhai Youwe Biotechnology Recent Developments/Updates

Table 121. Youwei (Zhuhai) Biotechnology Company Information

Table 122. Youwei (Zhuhai) Biotechnology Description and Business Overview

Table 123. Youwei (Zhuhai) Biotechnology Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 124. Youwei (Zhuhai) Biotechnology Transdermal Microarray Patches Product

Table 125. Youwei (Zhuhai) Biotechnology Recent Developments/Updates

Table 126. WCC Biomedical Company Information

Table 127. WCC Biomedical Description and Business Overview

Table 128. WCC Biomedical Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 129. WCC Biomedical Transdermal Microarray Patches Product

Table 130. WCC Biomedical Recent Developments/Updates

Table 131. Hisamitsu Pharmaceutical Company Information

Table 132. Hisamitsu Pharmaceutical Description and Business Overview

Table 133. Hisamitsu Pharmaceutical Transdermal Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)

Table 134. Hisamitsu Pharmaceutical Transdermal Microarray Patches Product

Table 135. Hisamitsu Pharmaceutical Recent Developments/Updates

Table 136. Key Raw Materials Lists

Table 137. Raw Materials Key Suppliers Lists

Table 138. Transdermal Microarray Patches Distributors List

Table 139. Transdermal Microarray Patches Customers List

Table 140. Transdermal Microarray Patches Market Trends

Table 141. Transdermal Microarray Patches Market Drivers

Table 142. Transdermal Microarray Patches Market Challenges

Table 143. Transdermal Microarray Patches Market Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

Table 147. Authors List of This Report

List of Figures

Figure 1. Product Picture of Transdermal Microarray Patches

Figure 2. Global Transdermal Microarray Patches Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Transdermal Microarray Patches Market Share by Type: 2025 & 2032

Figure 4. Dissolving Product Picture

Figure 5. Non-dissolving Product Picture

Figure 6. Global Transdermal Microarray Patches Market Value by Microneedle Material (US$ Million), 2021–2032

Figure 7. Global Transdermal Microarray Patches Market Share by Microneedle Material: 2025 vs 2032

Figure 8. Hyaluronic Acid Product Picture

Figure 9. Taurine Product Picture

Figure 10. Triple-helical Collagen Product Picture

Figure 11. PGA、PLA、PP Product Picture

Figure 12. Global Transdermal Microarray Patches Market Value by Application (US$ Million), 2021–2032

Figure 13. Global Transdermal Microarray Patches Market Share by Application: 2025 & 2032

Figure 14. Medical

Figure 15. Cosmetics

Figure 16. Global Transdermal Microarray Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Transdermal Microarray Patches Market Size (US$ Million), 2021–2032

Figure 18. Global Transdermal Microarray Patches Sales (K Pcs), 2021–2032

Figure 19. Global Transdermal Microarray Patches Average Price (US$/Pc), 2021–2032

Figure 20. Transdermal Microarray Patches Report Years Considered

Figure 21. Transdermal Microarray Patches Sales Share by Manufacturers in 2025

Figure 22. Global Transdermal Microarray Patches Revenue Share by Manufacturers in 2025

Figure 23. Top 5 and Top 10 Global Transdermal Microarray Patches Players: Market Share by Revenue in Transdermal Microarray Patches in 2025

Figure 24. Transdermal Microarray Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 25. Global Transdermal Microarray Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 26. North America Transdermal Microarray Patches Sales Market Share by Country (2021–2032)

Figure 27. North America Transdermal Microarray Patches Revenue Market Share by Country (2021–2032)

Figure 28. United States Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 29. Canada Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 30. Europe Transdermal Microarray Patches Sales Market Share by Country (2021–2032)

Figure 31. Europe Transdermal Microarray Patches Revenue Market Share by Country (2021–2032)

Figure 32. Germany Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 33. France Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. U.K. Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Italy Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Russia Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Asia Pacific Transdermal Microarray Patches Sales Market Share by Region (2021–2032)

Figure 38. Asia Pacific Transdermal Microarray Patches Revenue Market Share by Region (2021–2032)

Figure 39. China Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Japan Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. South Korea Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. India Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Australia Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. China Taiwan Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Southeast Asia Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Latin America Transdermal Microarray Patches Sales Market Share by Country (2021–2032)

Figure 47. Latin America Transdermal Microarray Patches Revenue Market Share by Country (2021–2032)

Figure 48. Mexico Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Brazil Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Argentina Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Colombia Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Middle East and Africa Transdermal Microarray Patches Sales Market Share by Country (2021–2032)

Figure 53. Middle East and Africa Transdermal Microarray Patches Revenue Market Share by Country (2021–2032)

Figure 54. Turkey Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Saudi Arabia Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. UAE Transdermal Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Global Sales Market Share of Transdermal Microarray Patches by Type (2021–2032)

Figure 58. Global Revenue Market Share of Transdermal Microarray Patches by Type (2021–2032)

Figure 59. Global Transdermal Microarray Patches Price (US$/Pc) by Type (2021–2032)

Figure 60. Global Sales Market Share of Transdermal Microarray Patches by Application (2021–2032)

Figure 61. Global Revenue Market Share of Transdermal Microarray Patches by Application (2021–2032)

Figure 62. Global Transdermal Microarray Patches Price (US$/Pc) by Application (2021–2032)

Figure 63. Transdermal Microarray Patches Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions